China Universal Asset Management Company’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
EA
EMFAT
China Universal Asset Management Company's COGT Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Cogent Biosciences (COGT) stake by 5.6% in Q2 2026, selling an estimated $56.3K and leaving 27,194 shares worth $1.05M. The position accounts for 0.06% of the portfolio, ranked #198.
China Universal Asset Management Company first reported a position in COGT in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.11M in Q1 2026. 143 funds tracked by Wall St. Rank hold COGT as of Q2 2026.
- China Universal Asset Management Company held 27,194 shares of Cogent Biosciences worth $1.05M as of Q2 2026.
- China Universal Asset Management Company sold 1,609 Cogent Biosciences shares in Q2 2026, an estimated $56.3K.
- Cogent Biosciences made up 0.06% of China Universal Asset Management Company's portfolio in Q2 2026, its #198 holding.
- China Universal Asset Management Company first reported a position in Cogent Biosciences in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Cogent Biosciences position peaked at $1.11M in Q1 2026.
- 143 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.